Thank you for speaking with us at The Liver Meeting®

Posted: November 14, 2018

New Biomarkers for Liver and Kidney Toxicity Studies

 

We enjoyed speaking with you at
The Liver Meeting®

 

New Biomarkers for Liver and Kidney Toxicity Studies

Thank you for taking a few minutes to discuss our panels of biomarkers for NAFLD, NASH, AH, and DILI research, featuring K18.

These mechanistic biomarkers provide insight into the biological processes occurring during liver injury.

  • M30 Apoptosense®
  • M65 EpiDeath®
  • M65® ELISA

Learn more about these and additional biomarkers for liver and metabolic diseases, like HA, α-GST, Collagen IV, FGF-21 and more, at diapharma.com, or contact your Territory Manager.

Research use only in the U.S. and Canada

New Biomarkers for Liver and Kidney Toxicity Studies

Diapharma Group, Inc., 8948 Beckett Rd., West Chester, OH 45069

ML-00-00394Rev01